ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 239

Does Adjusting BMI for Lean Mass Deficits Affect Calculated Fracture Risk Using FRAX in Rheumatoid Arthritis?

Brittany Adler1 and Joshua F. Baker2, 1Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 2Medicine/Rheumatology, University of Pennsylvania and Philadelphia VAMC, Philadelphia, PA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: DXA, Fracture risk, Osteoporosis and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Osteoporosis and Metabolic Bone Disease - Clinical Aspects and Pathogenesis: Osteoporosis: Pathogenesis, Epidemiology and Diagnosis

Session Type: Abstract Submissions (ACR)

Background/Purpose

Osteoporotic fractures are a cause of morbidity in rheumatoid arthritis (RA) and low body mass index (BMI) is a risk factor for osteoporotic fractures in RA. Emerging evidence suggests that low lean mass is responsible for bone structural deficits among those with low BMI. Therefore we hypothesized that adjusting BMI for lean mass deficits commonly seen in RA would alter prediction of risk using the FRAX tool. We studied the effect of utilizing a lean mass-adjusted BMI as an independent variable in the FRAX tool in the determination of fracture risk.

Methods

Whole-body dual energy absorptiometry (DXA) was previously performed in 40 RA subjects and 500 controls. We have previously identified independent associations between the total fat mass index (FMI) and appendicular lean mass index (ALMI) among 500 healthy control subjects. Based on our published model, we determined the expected ALMI for RA subjects based on their age, sex, race, and FMI.  We then multiplied the actual BMI by the ratio of the actual to expected ALMI to determine a lean mass-adjusted BMI. We calculated fracture risk among RA subjects using the FRAX calculator, and evaluated the differences in fracture risk prediction using the lean mass-adjusted BMI compared to the standard BMI both with and without using bone density results from DXA.

Results

Using the lean mass-adjusted BMI in place of standard BMI, the calculated risk of a major osteoporotic fracture increased in 21 (52.5%), decreased in 8 (20%), and was unchanged in 11 (27.5%) subjects. The mean absolute change in calculated 10-year major osteoporotic fracture risk using lean mass-adjusted BMI was 0.28% ± 0.70 (p=0.02).  Similarly, the calculated risk of hip fracture using lean mass-adjusted BMI was increased in 23 (57.5%), decreased in 6 (15%), and unchanged in 11 (27.5%) subjects. The mean absolute change in calculated 10-year hip fracture risk was 0.25% ± 0.60 (p=0.01).  The calculated risk of hip fracture using lean mass-adjusted BMI was most increased among subjects with a BMI <25 kg/m2. For subjects with a BMI<25 (n=11) the estimated fracture risk was significantly increased by 0.67% + 0.87 (p=0.03), as compared to -0.09% ±0.37 (p=0.2) for subjects with a BMI>25 (n=29) (p for comparison=0.005). When bone density at the hip was included into the FRAX calculation, the differences in calculated fracture risk using the lean mass-adjusted BMI and standard BMI were completely attenuated (Figure 1).

 Conclusion

Using lean mass-adjusted BMI in place of standard BMI in the FRAX equation results in an increase in calculated fracture risk for most patients with RA, particularly among those with a normal BMI (BMI<25). Incorporation of bone density measures significantly reduced these differences in risk prediction, which suggests that use of a lean mass-adjusted BMI would not affect risk prediction when bone density is available.

image001.jpg


Disclosure:

B. Adler,
None;

J. F. Baker,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/does-adjusting-bmi-for-lean-mass-deficits-affect-calculated-fracture-risk-using-frax-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology